v3.25.2
Condensed Consolidated Statement of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Ordinary Shares
Class A
Ordinary Shares
Class B
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Apr. 03, 2024
Balance (in Shares) at Apr. 03, 2024      
Issuance of Class B ordinary shares to Sponsor [1] $ 575 24,425 25,000
Issuance of Class B ordinary shares to Sponsor (in Shares) [1] 5,750,000      
Accretion for Class A ordinary shares to redemption amount (7,348,508) (13,715,174) (21,063,682)
Sale of 6,850,000 Private Placement Warrants 6,850,000 6,850,000
Fair value of Public Warrants at issuance 529,000 529,000
Allocated value of transaction costs (54,917) (54,917)
Net income 3,408,788 3,408,788
Balance at Dec. 31, 2024 $ 575 (10,306,386) (10,305,811)
Balance (in Shares) at Dec. 31, 2024 5,750,000      
Accretion for Class A ordinary shares to redemption amount (2,462,864) (2,462,864)
Net income 689,999 689,999
Balance at Mar. 31, 2025 $ 575 $ (12,079,251) $ (12,078,676)
Balance (in Shares) at Mar. 31, 2025 5,750,000      
[1] Included up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (Note 7). On August 19, 2024, the Company consummated its IPO and sold 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment, hence the 750,000 shares of Class B ordinary shares were no longer subject to forfeiture.